Global Neurovascular Devices Market - 2025 -2033
Neurovascular Devices Market Size
The global neurovascular devices market size reached US$ 3.82 Billion in 2024 from US$3.55 Billion in 2023 and is expected to reach US$ 7.78 Billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.
Neurovascular Devices Market Overview
The neurovascular devices market is a rapidly evolving sector within the broader medical devices industry, focused on the development and commercialization of specialized products designed to diagnose, treat, and manage neurovascular diseases such as ischemic and hemorrhagic strokes, cerebral aneurysms, and arteriovenous malformations. These devices include stents, flow diverters, embolic coils, thrombectomy devices, catheters, and microcatheters, among others.
The neurovascular devices market is moderately consolidated, with major players such as Medtronic, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, and Terumo Corporation leading product innovation and market penetration. Strategic acquisitions, partnerships, and ongoing R&D investments characterize the competitive dynamics, with smaller innovators contributing disruptive technologies.
Neurovascular Devices Market Dynamics
Drivers:
Rising technological advancements in neurovascular devices are significantly driving the market growth
Technological innovation is a major growth driver in the neurovascular devices market, enhancing procedural efficacy, safety, and expanding the range of treatable conditions. Advances enable minimally invasive interventions that reduce recovery time and improve patient outcomes, fueling higher adoption rates globally. Newer neurovascular devices, such as flow diverters, stent retrievers, and embolic coils, are designed to be less invasive, reducing recovery times and complications for patients. Thus, major market players are focusing on innovations, which are driving the market growth.
For instance, in February 2025, Penumbra launched the Access25 delivery microcatheter. Access25 is a single-lumen device designed to aid physicians in accessing the neurovasculature for delivery of Penumbra’s 0.020-inch coil platform. Access25 is compatible with Penumbra’s Midway intermediate catheters and Benchmark/BMX guide catheters. It is designed to facilitate ease of trackability and stable support when delivering Penumbra’s 0.020-inch coils for neurovascular embolization, such as PC400, POD400, and PAC400.
Devices now integrate with enhanced 2D and 3D imaging technologies, providing real-time visualization to guide procedures. This technology helps neurosurgeons place devices more precisely, ensuring safer and more effective treatments.
For instance, in February 2024, Royal Philips announced major enhancements to its Image Guided Therapy System, Azurion, with the launch of its new Azurion neuro biplane system. Designed to improve productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The new image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases.
The rising incidence of stroke and neurovascular disorders is also driving the neurovascular devices market growth
The increasing prevalence of neurovascular diseases, especially stroke, is a primary factor propelling the neurovascular devices market. Stroke is a leading cause of death and disability worldwide, creating a substantial demand for advanced diagnostic and therapeutic devices. According to the World Health Organization (WHO), over 15 million people suffer a stroke each year globally. Ischemic stroke, caused by blood clots blocking cerebral arteries, accounts for around 87% of all stroke cases. The increasing number of stroke cases directly correlates with the rising sales and adoption of these devices.
The rising global incidence of stroke and other neurovascular disorders is creating an urgent need for advanced, effective treatment options. This epidemiological trend directly drives the expansion of the neurovascular devices market by increasing patient numbers, encouraging technological innovation, and prompting healthcare system investments.
Restraints:
Competition from alternative therapies is hampering the growth of the neurovascular devices market
Many neurovascular disorders, such as ischemic stroke or cerebral aneurysms, can be treated using medications rather than interventional devices. Pharmacological treatments like antiplatelet drugs (e.g., aspirin) and anticoagulants (e.g., warfarin, rivaroxaban) can prevent clot formation and reduce the risk of stroke or aneurysm rupture. For instance, the use of thrombolytics (e.g., tissue plasminogen activator, tPA) for acute ischemic stroke can often reduce the need for thrombectomy or other device-based interventions, thus limiting demand for neurovascular devices.
In some situations, traditional open surgery remains the preferred option, especially for complex or large aneurysms and arteriovenous malformations (AVMs). Although less commonly used than minimally invasive methods, open surgery can be seen as a more established and reliable option. For instance, for patients with large or difficult-to-treat brain aneurysms, clipping surgery may be recommended over embolization or flow diversion, which can reduce the market share of neurovascular devices.
Alternatives like stereotactic radiosurgery or laser ablation are sometimes preferred for treating brain tumors, arteriovenous malformations, and other vascular lesions. These methods can offer less risk and are less invasive than traditional neurovascular procedures. For instance, Gamma Knife radiosurgery is frequently used as an alternative to embolization or surgical resection for AVMs, particularly for small lesions.
Opportunities:
Miniaturization and flexible design of devices create a market opportunity for the neurovascular devices market
Advancements in miniaturization and flexible device design are transforming neurovascular interventions by enabling access to increasingly complex and delicate cerebral vasculature. This innovation expands treatment possibilities, improves clinical outcomes, and opens new market segments. Smaller, more flexible microcatheters, stents, and coils can navigate narrow, winding blood vessels deep within the brain. This capability allows treatment of previously untreatable conditions like distal aneurysms, small arteriovenous malformations, and pediatric neurovascular disorders.
Miniaturized devices cater to smaller vessels in pediatric patients and fragile vessels in elderly patients. This niche is underserved but growing, offering manufacturers differentiation opportunities. Flexible devices reduce the risk of vessel injury, perforation, or dissection. Improved maneuverability shortens procedure duration, which is critical in acute stroke management where every minute counts. This increases physician confidence and broadens device adoption.
Neurovascular Devices Market, Segment Analysis
The global neurovascular devices market is segmented based on product type, application, end-user, and region.
The cerebral angioplasty and stenting systems from the product type segment are expected to hold 38.13% of the market share in 2024 in the neurovascular devices market
Over the years, technological advancements in angioplasty and stenting systems have improved treatment efficacy, safety, and patient outcomes. The development of self-expanding stents, drug-eluting stents, and balloon angioplasty systems has enhanced the precision and success rates of neurovascular procedures. Market players are developing advanced stenting systems, which are driving the segment growth.
For instance, in May 2025, Terumo Interventional Systems announced the early commercial availability of its FDA-approved Roadsaver carotid stent system. The Roadsaver carotid stent system, when used in conjunction with Terumo’s Nanoparasol embolic protection system, is indicated for the treatment of carotid artery stenosis in patients with elevated risk for adverse events after carotid endarterectomy.
Cerebral angioplasty and stenting are minimally invasive procedures, which are preferred by both patients and physicians because they involve smaller incisions, reduced recovery times, and fewer complications compared to traditional open surgeries. For instance, angioplasty with stenting for carotid artery disease is performed through a small incision in the groin, making it a less traumatic alternative to surgery. This less invasive nature drives higher adoption of stenting systems in treating neurovascular diseases.
Neurovascular Devices Market, Geographical Analysis
North America is expected to dominate the global neurovascular devices market with a 42.78% share in 2024
North America, especially the United States, is a hub for innovation in medical devices, with leading companies such as Medtronic, Stryker Corporation, Terumo Corporation, and other emerging market players developing new and improved neurovascular devices. This includes the development of stent retrievers, flow diverters, and clot removal devices that are highly effective in treating stroke and aneurysms.
For instance, in February 2024, CERENOVUS, Inc., part of Johnson & Johnson MedTech, launched CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse indicated for the revascularization of patients suffering from acute ischemic stroke. CEREGLIDE 71 Intermediate Catheter is the latest innovation in a planned CEREGLIDE Family of Catheters to join the CERENOVUS STROKE SOLUTIONS portfolio and is optimized for effective direct aspiration and the delivery of compatible stent retrievers, including the EMBOTRAP III Revascularization Device, into the neurovasculature.
Similarly, in June 2024, Terumo subsidiary MicroVention launched its LVIS EVO intraluminal support device to treat wide-neck intracranial aneurysms in the U.S. The device is indicated for use with neurovascular embolization coils in adults to treat saccular intracranial aneurysms with a neck width of 4 mm or greater or a dome-to-neck ratio of less than two that arise from a parent vessel with a diameter between 2 and 4.5 mm.
Asia-Pacific is growing at the fastest pace in the neurovascular devices market holding 21.42% of the market share
The APAC region has a growing incidence of stroke, aneurysms, and carotid artery diseases due to lifestyle factors, rising levels of hypertension, smoking, and diabetes, which are risk factors for neurovascular conditions. For instance, the World Health Organization (WHO) reports that Asia, particularly China and India, has a high incidence of ischemic stroke, with nearly 70% of all strokes occurring in low- and middle-income countries in Asia. This significantly boosts the demand for neurovascular devices such as stents, coils, and thrombectomy systems.
There is an increasing awareness of minimally invasive neurovascular procedures such as stenting, angioplasty, and thrombectomy in the Asia Pacific region. As healthcare professionals and patients become more informed about the benefits of these procedures, the demand for neurovascular devices increases. For instance, the use of thrombectomy systems like the Solitaire FR Stent Retriever is growing in countries like India and China as part of the initiative to improve stroke treatment outcomes.
Neurovascular Devices Market Competitive Landscape
Top companies in the neurovascular devices market include Medtronic, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Johnson & Johnson, Penumbra, Inc., ASAHI INTECC USA, INC., Acandis GmbH, Rapid Medical, and NeuroVasc Technologies, Inc., among others.
The global neurovascular devices market report delivers a detailed analysis with 62 key tables, more than 57 visually impactful figures, and 146 pages of expert insights, providing a complete view of the market landscape.
The global neurovascular devices market size reached US$ 3.82 Billion in 2024 from US$3.55 Billion in 2023 and is expected to reach US$ 7.78 Billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.
Neurovascular Devices Market Overview
The neurovascular devices market is a rapidly evolving sector within the broader medical devices industry, focused on the development and commercialization of specialized products designed to diagnose, treat, and manage neurovascular diseases such as ischemic and hemorrhagic strokes, cerebral aneurysms, and arteriovenous malformations. These devices include stents, flow diverters, embolic coils, thrombectomy devices, catheters, and microcatheters, among others.
The neurovascular devices market is moderately consolidated, with major players such as Medtronic, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, and Terumo Corporation leading product innovation and market penetration. Strategic acquisitions, partnerships, and ongoing R&D investments characterize the competitive dynamics, with smaller innovators contributing disruptive technologies.
Neurovascular Devices Market Dynamics
Drivers:
Rising technological advancements in neurovascular devices are significantly driving the market growth
Technological innovation is a major growth driver in the neurovascular devices market, enhancing procedural efficacy, safety, and expanding the range of treatable conditions. Advances enable minimally invasive interventions that reduce recovery time and improve patient outcomes, fueling higher adoption rates globally. Newer neurovascular devices, such as flow diverters, stent retrievers, and embolic coils, are designed to be less invasive, reducing recovery times and complications for patients. Thus, major market players are focusing on innovations, which are driving the market growth.
For instance, in February 2025, Penumbra launched the Access25 delivery microcatheter. Access25 is a single-lumen device designed to aid physicians in accessing the neurovasculature for delivery of Penumbra’s 0.020-inch coil platform. Access25 is compatible with Penumbra’s Midway intermediate catheters and Benchmark/BMX guide catheters. It is designed to facilitate ease of trackability and stable support when delivering Penumbra’s 0.020-inch coils for neurovascular embolization, such as PC400, POD400, and PAC400.
Devices now integrate with enhanced 2D and 3D imaging technologies, providing real-time visualization to guide procedures. This technology helps neurosurgeons place devices more precisely, ensuring safer and more effective treatments.
For instance, in February 2024, Royal Philips announced major enhancements to its Image Guided Therapy System, Azurion, with the launch of its new Azurion neuro biplane system. Designed to improve productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The new image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases.
The rising incidence of stroke and neurovascular disorders is also driving the neurovascular devices market growth
The increasing prevalence of neurovascular diseases, especially stroke, is a primary factor propelling the neurovascular devices market. Stroke is a leading cause of death and disability worldwide, creating a substantial demand for advanced diagnostic and therapeutic devices. According to the World Health Organization (WHO), over 15 million people suffer a stroke each year globally. Ischemic stroke, caused by blood clots blocking cerebral arteries, accounts for around 87% of all stroke cases. The increasing number of stroke cases directly correlates with the rising sales and adoption of these devices.
The rising global incidence of stroke and other neurovascular disorders is creating an urgent need for advanced, effective treatment options. This epidemiological trend directly drives the expansion of the neurovascular devices market by increasing patient numbers, encouraging technological innovation, and prompting healthcare system investments.
Restraints:
Competition from alternative therapies is hampering the growth of the neurovascular devices market
Many neurovascular disorders, such as ischemic stroke or cerebral aneurysms, can be treated using medications rather than interventional devices. Pharmacological treatments like antiplatelet drugs (e.g., aspirin) and anticoagulants (e.g., warfarin, rivaroxaban) can prevent clot formation and reduce the risk of stroke or aneurysm rupture. For instance, the use of thrombolytics (e.g., tissue plasminogen activator, tPA) for acute ischemic stroke can often reduce the need for thrombectomy or other device-based interventions, thus limiting demand for neurovascular devices.
In some situations, traditional open surgery remains the preferred option, especially for complex or large aneurysms and arteriovenous malformations (AVMs). Although less commonly used than minimally invasive methods, open surgery can be seen as a more established and reliable option. For instance, for patients with large or difficult-to-treat brain aneurysms, clipping surgery may be recommended over embolization or flow diversion, which can reduce the market share of neurovascular devices.
Alternatives like stereotactic radiosurgery or laser ablation are sometimes preferred for treating brain tumors, arteriovenous malformations, and other vascular lesions. These methods can offer less risk and are less invasive than traditional neurovascular procedures. For instance, Gamma Knife radiosurgery is frequently used as an alternative to embolization or surgical resection for AVMs, particularly for small lesions.
Opportunities:
Miniaturization and flexible design of devices create a market opportunity for the neurovascular devices market
Advancements in miniaturization and flexible device design are transforming neurovascular interventions by enabling access to increasingly complex and delicate cerebral vasculature. This innovation expands treatment possibilities, improves clinical outcomes, and opens new market segments. Smaller, more flexible microcatheters, stents, and coils can navigate narrow, winding blood vessels deep within the brain. This capability allows treatment of previously untreatable conditions like distal aneurysms, small arteriovenous malformations, and pediatric neurovascular disorders.
Miniaturized devices cater to smaller vessels in pediatric patients and fragile vessels in elderly patients. This niche is underserved but growing, offering manufacturers differentiation opportunities. Flexible devices reduce the risk of vessel injury, perforation, or dissection. Improved maneuverability shortens procedure duration, which is critical in acute stroke management where every minute counts. This increases physician confidence and broadens device adoption.
Neurovascular Devices Market, Segment Analysis
The global neurovascular devices market is segmented based on product type, application, end-user, and region.
The cerebral angioplasty and stenting systems from the product type segment are expected to hold 38.13% of the market share in 2024 in the neurovascular devices market
Over the years, technological advancements in angioplasty and stenting systems have improved treatment efficacy, safety, and patient outcomes. The development of self-expanding stents, drug-eluting stents, and balloon angioplasty systems has enhanced the precision and success rates of neurovascular procedures. Market players are developing advanced stenting systems, which are driving the segment growth.
For instance, in May 2025, Terumo Interventional Systems announced the early commercial availability of its FDA-approved Roadsaver carotid stent system. The Roadsaver carotid stent system, when used in conjunction with Terumo’s Nanoparasol embolic protection system, is indicated for the treatment of carotid artery stenosis in patients with elevated risk for adverse events after carotid endarterectomy.
Cerebral angioplasty and stenting are minimally invasive procedures, which are preferred by both patients and physicians because they involve smaller incisions, reduced recovery times, and fewer complications compared to traditional open surgeries. For instance, angioplasty with stenting for carotid artery disease is performed through a small incision in the groin, making it a less traumatic alternative to surgery. This less invasive nature drives higher adoption of stenting systems in treating neurovascular diseases.
Neurovascular Devices Market, Geographical Analysis
North America is expected to dominate the global neurovascular devices market with a 42.78% share in 2024
North America, especially the United States, is a hub for innovation in medical devices, with leading companies such as Medtronic, Stryker Corporation, Terumo Corporation, and other emerging market players developing new and improved neurovascular devices. This includes the development of stent retrievers, flow diverters, and clot removal devices that are highly effective in treating stroke and aneurysms.
For instance, in February 2024, CERENOVUS, Inc., part of Johnson & Johnson MedTech, launched CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse indicated for the revascularization of patients suffering from acute ischemic stroke. CEREGLIDE 71 Intermediate Catheter is the latest innovation in a planned CEREGLIDE Family of Catheters to join the CERENOVUS STROKE SOLUTIONS portfolio and is optimized for effective direct aspiration and the delivery of compatible stent retrievers, including the EMBOTRAP III Revascularization Device, into the neurovasculature.
Similarly, in June 2024, Terumo subsidiary MicroVention launched its LVIS EVO intraluminal support device to treat wide-neck intracranial aneurysms in the U.S. The device is indicated for use with neurovascular embolization coils in adults to treat saccular intracranial aneurysms with a neck width of 4 mm or greater or a dome-to-neck ratio of less than two that arise from a parent vessel with a diameter between 2 and 4.5 mm.
Asia-Pacific is growing at the fastest pace in the neurovascular devices market holding 21.42% of the market share
The APAC region has a growing incidence of stroke, aneurysms, and carotid artery diseases due to lifestyle factors, rising levels of hypertension, smoking, and diabetes, which are risk factors for neurovascular conditions. For instance, the World Health Organization (WHO) reports that Asia, particularly China and India, has a high incidence of ischemic stroke, with nearly 70% of all strokes occurring in low- and middle-income countries in Asia. This significantly boosts the demand for neurovascular devices such as stents, coils, and thrombectomy systems.
There is an increasing awareness of minimally invasive neurovascular procedures such as stenting, angioplasty, and thrombectomy in the Asia Pacific region. As healthcare professionals and patients become more informed about the benefits of these procedures, the demand for neurovascular devices increases. For instance, the use of thrombectomy systems like the Solitaire FR Stent Retriever is growing in countries like India and China as part of the initiative to improve stroke treatment outcomes.
Neurovascular Devices Market Competitive Landscape
Top companies in the neurovascular devices market include Medtronic, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Johnson & Johnson, Penumbra, Inc., ASAHI INTECC USA, INC., Acandis GmbH, Rapid Medical, and NeuroVasc Technologies, Inc., among others.
The global neurovascular devices market report delivers a detailed analysis with 62 key tables, more than 57 visually impactful figures, and 146 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Product Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Technological Advancements in Neurovascular Devices
4.1.1.2. Rising Incidence of Stroke and Neurovascular Disorders
4.1.1.3. Strategic Collaborations and Acquisitions
4.1.2. Restraints
4.1.2.1. Competition from Alternative Therapies
4.1.2.2. High Procedural and Device Costs
4.1.2.3. Device-Related Complications and Safety Concerns
4.1.3. Opportunity
4.1.3.1. Miniaturization and Flexible Design of Devices
4.1.3.2. Integration of Artificial Intelligence and Robotics
4.1.3.3. Expansion into Emerging Markets
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. NEUROVASCULAR DEVICES MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Cerebral Embolization and Aneurysm Coiling Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Embolic Coils
6.2.4. Flow Diversion Devices
6.2.5. Liquid Embolic Agents
6.3. Cerebral Angioplasty and Stenting Systems
6.3.1. Carotid Artery Stents
6.3.2. Embolic Protection Systems
6.4. Neurothrombectomy Devices
6.4.1. Clot Retrieval Devices
6.4.2. Suction Devices/Aspiration Catheters
6.4.3. Vascular Snares
6.5. Support Devices
6.5.1. Micro Catheters
6.5.2. Micro Guidewires
6.6. Trans Radial Access Devices
7. NEUROVASCULAR DEVICES MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Cerebral Aneurysms*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ischemic Stroke
7.4. Carotid Artery Stenosis
7.5. Others
8. NEUROVASCULAR DEVICES MARKET, BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Surgical Centers
8.5. Research Laboratories and Academic Institutes
8.6. Ambulatory Surgical Centers
9. NEUROVASCULAR DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10. INTRODUCTION
10.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.1. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Spain
10.3.6.5. Italy
10.3.6.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. China
10.4.6.2. India
10.4.6.3. Japan
10.4.6.4. South Korea
10.4.6.5. Rest of Asia-Pacific
10.5. South America
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Brazil
10.5.6.2. Argentina
10.5.6.3. Rest of South America
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. Medtronic*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.3. Financial Overview
13.1.4. Company Revenue
13.1.5. Geographical Revenue Shares
13.1.5.1. Revenue Forecasts
13.1.6. Key Developments
13.1.6.1. Mergers & Acquisitions
13.1.6.2. Key Product Development Activities
13.1.6.3. Regulatory Approvals, etc.
13.1.7. SWOT Analysis
13.2. Stryker Corporation
13.3. Terumo Corporation
13.4. MicroPort Scientific Corporation
13.5. Johnson & Johnson
13.6. Penumbra, Inc.
13.7. ASAHI INTECC USA, INC.
13.8. Acandis GmbH
13.9. Rapid Medical
13.10. NeuroVasc Technologies, Inc. ( LIST NOT EXHAUSTIVE)
14. ASSUMPTIONS AND RESEARCH METHODOLOGY
14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Product Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Technological Advancements in Neurovascular Devices
4.1.1.2. Rising Incidence of Stroke and Neurovascular Disorders
4.1.1.3. Strategic Collaborations and Acquisitions
4.1.2. Restraints
4.1.2.1. Competition from Alternative Therapies
4.1.2.2. High Procedural and Device Costs
4.1.2.3. Device-Related Complications and Safety Concerns
4.1.3. Opportunity
4.1.3.1. Miniaturization and Flexible Design of Devices
4.1.3.2. Integration of Artificial Intelligence and Robotics
4.1.3.3. Expansion into Emerging Markets
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. NEUROVASCULAR DEVICES MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Cerebral Embolization and Aneurysm Coiling Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Embolic Coils
6.2.4. Flow Diversion Devices
6.2.5. Liquid Embolic Agents
6.3. Cerebral Angioplasty and Stenting Systems
6.3.1. Carotid Artery Stents
6.3.2. Embolic Protection Systems
6.4. Neurothrombectomy Devices
6.4.1. Clot Retrieval Devices
6.4.2. Suction Devices/Aspiration Catheters
6.4.3. Vascular Snares
6.5. Support Devices
6.5.1. Micro Catheters
6.5.2. Micro Guidewires
6.6. Trans Radial Access Devices
7. NEUROVASCULAR DEVICES MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Cerebral Aneurysms*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ischemic Stroke
7.4. Carotid Artery Stenosis
7.5. Others
8. NEUROVASCULAR DEVICES MARKET, BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Surgical Centers
8.5. Research Laboratories and Academic Institutes
8.6. Ambulatory Surgical Centers
9. NEUROVASCULAR DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10. INTRODUCTION
10.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.1. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Spain
10.3.6.5. Italy
10.3.6.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. China
10.4.6.2. India
10.4.6.3. Japan
10.4.6.4. South Korea
10.4.6.5. Rest of Asia-Pacific
10.5. South America
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Brazil
10.5.6.2. Argentina
10.5.6.3. Rest of South America
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. Medtronic*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.3. Financial Overview
13.1.4. Company Revenue
13.1.5. Geographical Revenue Shares
13.1.5.1. Revenue Forecasts
13.1.6. Key Developments
13.1.6.1. Mergers & Acquisitions
13.1.6.2. Key Product Development Activities
13.1.6.3. Regulatory Approvals, etc.
13.1.7. SWOT Analysis
13.2. Stryker Corporation
13.3. Terumo Corporation
13.4. MicroPort Scientific Corporation
13.5. Johnson & Johnson
13.6. Penumbra, Inc.
13.7. ASAHI INTECC USA, INC.
13.8. Acandis GmbH
13.9. Rapid Medical
13.10. NeuroVasc Technologies, Inc. ( LIST NOT EXHAUSTIVE)
14. ASSUMPTIONS AND RESEARCH METHODOLOGY
14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
LIST OF TABLES
Table 1 Global Neurovascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Neurovascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Neurovascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Neurovascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Neurovascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Neurovascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Neurovascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Neurovascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Neurovascular Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 South America Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 South America Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Medtronic: Overview
Table 34 Medtronic: Product Portfolio
Table 35 Medtronic: Key Developments
Table 36 Stryker Corporation: Overview
Table 37 Stryker Corporation: Product Portfolio
Table 38 Stryker Corporation: Key Developments
Table 39 Terumo Corporation: Overview
Table 40 Terumo Corporation: Product Portfolio
Table 41 Terumo Corporation: Key Developments
Table 42 MicroPort Scientific Corporation: Overview
Table 43 MicroPort Scientific Corporation: Product Portfolio
Table 44 MicroPort Scientific Corporation: Key Developments
Table 45 Johnson & Johnson: Overview
Table 46 Johnson & Johnson: Product Portfolio
Table 47 Johnson & Johnson: Key Developments
Table 48 Penumbra, Inc.: Overview
Table 49 Penumbra, Inc.: Product Portfolio
Table 50 Penumbra, Inc.: Key Developments
Table 51 ASAHI INTECC USA, INC.: Overview
Table 52 ASAHI INTECC USA, INC.: Product Portfolio
Table 53 ASAHI INTECC USA, INC.: Key Developments
Table 54 Acandis GmbH: Overview
Table 55 Acandis GmbH: Product Portfolio
Table 56 Acandis GmbH: Key Developments
Table 57 Rapid Medical: Overview
Table 58 Rapid Medical: Product Portfolio
Table 59 Rapid Medical: Key Developments
Table 60 NeuroVasc Technologies, Inc.: Overview
Table 61 NeuroVasc Technologies, Inc.: Product Portfolio
Table 62 NeuroVasc Technologies, Inc.: Key Developments
Table 1 Global Neurovascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Neurovascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Neurovascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Neurovascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Neurovascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Neurovascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Neurovascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Neurovascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Neurovascular Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 South America Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 South America Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Neurovascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Neurovascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Neurovascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Neurovascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Medtronic: Overview
Table 34 Medtronic: Product Portfolio
Table 35 Medtronic: Key Developments
Table 36 Stryker Corporation: Overview
Table 37 Stryker Corporation: Product Portfolio
Table 38 Stryker Corporation: Key Developments
Table 39 Terumo Corporation: Overview
Table 40 Terumo Corporation: Product Portfolio
Table 41 Terumo Corporation: Key Developments
Table 42 MicroPort Scientific Corporation: Overview
Table 43 MicroPort Scientific Corporation: Product Portfolio
Table 44 MicroPort Scientific Corporation: Key Developments
Table 45 Johnson & Johnson: Overview
Table 46 Johnson & Johnson: Product Portfolio
Table 47 Johnson & Johnson: Key Developments
Table 48 Penumbra, Inc.: Overview
Table 49 Penumbra, Inc.: Product Portfolio
Table 50 Penumbra, Inc.: Key Developments
Table 51 ASAHI INTECC USA, INC.: Overview
Table 52 ASAHI INTECC USA, INC.: Product Portfolio
Table 53 ASAHI INTECC USA, INC.: Key Developments
Table 54 Acandis GmbH: Overview
Table 55 Acandis GmbH: Product Portfolio
Table 56 Acandis GmbH: Key Developments
Table 57 Rapid Medical: Overview
Table 58 Rapid Medical: Product Portfolio
Table 59 Rapid Medical: Key Developments
Table 60 NeuroVasc Technologies, Inc.: Overview
Table 61 NeuroVasc Technologies, Inc.: Product Portfolio
Table 62 NeuroVasc Technologies, Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Neurovascular Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Neurovascular Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Cerebral Embolization and Aneurysm Coiling Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Cerebral Angioplasty and Stenting Systems Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Neurothrombectomy Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Support Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Trans Radial Access Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Neurovascular Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 13 Cerebral Aneurysms Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Ischemic Stroke Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Carotid Artery Stenosis Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Others Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Neurovascular Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 18 Hospitals End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Specialty Clinics End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Surgical Centers End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Research Laboratories and Academic Institutes End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Ambulatory Surgical Centers End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Neurovascular Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 24 North America Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 North America Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 26 North America Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 27 North America Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 28 North America Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 29 South America Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 30 South America Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 31 South America Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 32 South America Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 33 South America Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 34 Europe Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 35 Europe Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 36 Europe Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 37 Europe Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 38 Europe Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 39 Asia-Pacific Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 40 Asia-Pacific Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Asia-Pacific Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 42 Asia-Pacific Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 43 Asia-Pacific Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 44 Middle East and Africa Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 45 Middle East and Africa Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 46 Middle East and Africa Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 47 Middle East and Africa Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 48 Medtronic: Financials
Figure 49 Stryker Corporation: Financials
Figure 50 Terumo Corporation: Financials
Figure 51 MicroPort Scientific Corporation: Financials
Figure 52 Johnson & Johnson: Financials
Figure 53 Penumbra, Inc.: Financials
Figure 54 ASAHI INTECC USA, INC.: Financials
Figure 55 Acandis GmbH: Financials
Figure 56 Rapid Medical: Financials
Figure 57 NeuroVasc Technologies, Inc.: Financials
Figure 1 Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Neurovascular Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Neurovascular Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Cerebral Embolization and Aneurysm Coiling Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Cerebral Angioplasty and Stenting Systems Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Neurothrombectomy Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Support Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Trans Radial Access Devices Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Neurovascular Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 13 Cerebral Aneurysms Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Ischemic Stroke Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Carotid Artery Stenosis Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Others Application in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Neurovascular Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 18 Hospitals End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Specialty Clinics End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Surgical Centers End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Research Laboratories and Academic Institutes End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Ambulatory Surgical Centers End-User in Global Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Neurovascular Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 24 North America Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 North America Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 26 North America Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 27 North America Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 28 North America Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 29 South America Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 30 South America Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 31 South America Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 32 South America Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 33 South America Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 34 Europe Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 35 Europe Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 36 Europe Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 37 Europe Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 38 Europe Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 39 Asia-Pacific Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 40 Asia-Pacific Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Asia-Pacific Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 42 Asia-Pacific Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 43 Asia-Pacific Neurovascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 44 Middle East and Africa Neurovascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 45 Middle East and Africa Neurovascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 46 Middle East and Africa Neurovascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 47 Middle East and Africa Neurovascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 48 Medtronic: Financials
Figure 49 Stryker Corporation: Financials
Figure 50 Terumo Corporation: Financials
Figure 51 MicroPort Scientific Corporation: Financials
Figure 52 Johnson & Johnson: Financials
Figure 53 Penumbra, Inc.: Financials
Figure 54 ASAHI INTECC USA, INC.: Financials
Figure 55 Acandis GmbH: Financials
Figure 56 Rapid Medical: Financials
Figure 57 NeuroVasc Technologies, Inc.: Financials
